A CMAP, or compound muscle action potential, is an electrical signal recorded from a muscle during a nerve conduction study. It represents the combined response of all the muscle fibers in a given muscle when the nerve controlling that muscle is stimulated with a small electrical pulse. Doctors use it to assess how well motor nerves are functioning and whether muscle tissue is responding normally.
How a CMAP Is Generated
Your muscles are organized into units called motor units. Each motor unit consists of a single nerve fiber and all the muscle fibers it controls. When a technician applies an electrical stimulus to a motor nerve during a nerve conduction study, all of the motor units in the target muscle fire at nearly the same time. The electrical signals from those individual muscle fibers add together, and the combined wave is what gets recorded as the CMAP.
The recording is done with a surface electrode placed on the skin directly over the muscle being tested. A second electrode nearby serves as a reference point. The “action” in the name refers to the fact that this signal is deliberately triggered by nerve stimulation, not something the muscle produces on its own. Sometimes called the M wave, the CMAP is essentially a summation signal: the more healthy motor units firing beneath the electrode, the larger the waveform.
What a CMAP Measures
Several features of the CMAP waveform give clinicians useful diagnostic information:
- Amplitude: The height of the waveform, measured in millivolts. This reflects how many muscle fibers responded to the stimulus. A lower amplitude generally means fewer functioning motor units, which can indicate nerve damage or muscle loss.
- Distal latency: The time between the electrical stimulus and the start of the muscle response. This tells clinicians how quickly the signal travels along the nerve to the muscle. A longer-than-normal latency suggests the nerve’s insulating coating (myelin) is damaged, slowing conduction.
- Duration: How long the waveform lasts from start to finish. A prolonged duration can indicate that different nerve fibers are conducting at different speeds, causing the muscle fibers to fire out of sync.
- Area: The total area under the waveform curve, which accounts for both amplitude and duration. This provides a more complete picture of how much muscle tissue is activating.
What Happens During the Test
A nerve conduction study is performed in a clinic or hospital setting, typically by a neurologist or trained technician. You’ll sit or lie down while adhesive surface electrodes are placed on the skin over the muscle being studied. Common test sites include the hand muscles (supplied by the median and ulnar nerves), the forearm, and the lower leg.
A handheld stimulator delivers brief electrical pulses to the nerve at one or more points along its path. Each pulse feels like a quick, sharp tap or mild shock. The intensity is gradually increased until the nerve is fully activated, ensuring every motor unit contributes to the response. This “supramaximal” stimulation produces the largest possible CMAP, giving an accurate picture of the nerve and muscle’s full capacity. The whole process for a single nerve usually takes just a few minutes.
Axonal Loss vs. Demyelination
The pattern of CMAP changes helps distinguish between two fundamentally different types of nerve damage. When nerve fibers themselves are destroyed (axonal loss), the CMAP amplitude drops because fewer fibers are available to carry the signal to the muscle. However, the amplitude doesn’t always fall in direct proportion to the number of lost nerve fibers. Surviving motor nerves can sprout new branches to reinnervate orphaned muscle fibers, a process called collateral reinnervation. This compensatory mechanism means the CMAP amplitude may appear relatively preserved even when a significant number of nerve fibers have been lost.
Demyelination tells a different story. When the myelin sheath surrounding nerve fibers is damaged, signals slow down rather than disappear. The hallmarks are prolonged distal latency and reduced conduction velocity, while amplitude may remain closer to normal early on. In many real-world cases, both processes occur together, producing a mixed pattern of reduced amplitude and slowed conduction.
Conditions Associated With Abnormal CMAP Results
A reduced CMAP amplitude appears in a wide range of neuromuscular conditions. Among the more common are amyotrophic lateral sclerosis (ALS), various forms of Charcot-Marie-Tooth disease, spinal muscular atrophy, and certain congenital myasthenic syndromes where the connection between nerve and muscle is impaired. Guillain-Barré syndrome and chronic inflammatory demyelinating polyneuropathy (CIDP) can produce both demyelinating and axonal patterns depending on the stage and severity of the disease.
A low CMAP alone doesn’t point to a single diagnosis. Clinicians interpret it alongside other findings from the nerve conduction study, needle electromyography, clinical symptoms, and sometimes blood work or imaging to narrow down the cause.
CMAP in Repetitive Nerve Stimulation
A specialized variation of the test, called repetitive nerve stimulation, uses the CMAP to evaluate conditions that affect the junction between nerve and muscle. In this protocol, the nerve is stimulated several times in a row, typically with six pulses delivered at three per second. In a healthy person, the CMAP amplitude stays roughly the same with each pulse. In someone with myasthenia gravis, the amplitude progressively drops because the neuromuscular junction fails to transmit signals reliably with repeated use.
A decline of more than 10% between the first and lowest CMAP (usually the fourth or fifth in the series) is considered abnormal. This test is more sensitive in people with generalized myasthenia gravis, where it detects the condition about 72% of the time, compared to roughly 39% in people with symptoms limited to the eyes.
Factors That Affect Accuracy
Limb temperature is one of the most important variables that can skew CMAP results. When skin and muscle are cold, individual nerve and muscle fiber signals become taller and longer. The peak height of a single action potential increases, and the time it takes to return to baseline rises by as much as 69%. This means a CMAP recorded from a cold hand could look artificially large in amplitude and prolonged in duration. Testing labs typically measure skin temperature before the study and warm the limb if it falls below a standard threshold, usually around 32°C (about 90°F) at the hand.
Electrode placement also matters. If the recording electrode isn’t centered over the muscle’s motor point (the spot where the nerve enters the muscle), the initial part of the waveform may look distorted, making measurements less reliable. Age, height, and individual anatomy can all influence normal values, which is why results are compared against reference ranges adjusted for these factors.